DexCom Revenue 2010-2024 | DXCM

DexCom annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • DexCom revenue for the quarter ending March 31, 2024 was $0.921B, a 24.21% increase year-over-year.
  • DexCom revenue for the twelve months ending March 31, 2024 was $3.802B, a 25.78% increase year-over-year.
  • DexCom annual revenue for 2023 was $3.622B, a 24.49% increase from 2022.
  • DexCom annual revenue for 2022 was $2.91B, a 18.84% increase from 2021.
  • DexCom annual revenue for 2021 was $2.449B, a 27.08% increase from 2020.
DexCom Annual Revenue
(Millions of US $)
2023 $3,622
2022 $2,910
2021 $2,449
2020 $1,927
2019 $1,476
2018 $1,032
2017 $719
2016 $573
2015 $402
2014 $259
2013 $160
2012 $100
2011 $76
2010 $49
2009 $30
DexCom Quarterly Revenue
(Millions of US $)
2024-03-31 $921
2023-12-31 $1,035
2023-09-30 $975
2023-06-30 $871
2023-03-31 $742
2022-12-31 $815
2022-09-30 $770
2022-06-30 $696
2022-03-31 $629
2021-12-31 $698
2021-09-30 $650
2021-06-30 $595
2021-03-31 $505
2020-12-31 $569
2020-09-30 $501
2020-06-30 $452
2020-03-31 $405
2019-12-31 $463
2019-09-30 $396
2019-06-30 $336
2019-03-31 $281
2018-12-31 $338
2018-09-30 $267
2018-06-30 $243
2018-03-31 $184
2017-12-31 $221
2017-09-30 $185
2017-06-30 $171
2017-03-31 $142
2016-12-31 $171
2016-09-30 $149
2016-06-30 $137
2016-03-31 $116
2015-12-31 $131
2015-09-30 $105
2015-06-30 $93
2015-03-31 $73
2014-12-31 $84
2014-09-30 $69
2014-06-30 $59
2014-03-31 $47
2013-12-31 $52
2013-09-30 $43
2013-06-30 $36
2013-03-31 $30
2012-12-31 $33
2012-09-30 $23
2012-06-30 $23
2012-03-31 $20
2011-12-31 $22
2011-09-30 $18
2011-06-30 $21
2011-03-31 $14
2010-12-31 $16
2010-09-30 $12
2010-06-30 $12
2010-03-31 $10
2009-12-31 $10
2009-09-30 $7
2009-06-30 $7
2009-03-31 $5
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $51.910B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $225.518B 27.33
Intuitive Surgical (ISRG) United States $142.199B 85.66
Edwards Lifesciences (EW) United States $54.361B 35.38
Alcon (ALC) Switzerland $44.749B 32.07
IDEXX Laboratories (IDXX) United States $42.775B 50.14
IQVIA Holdings (IQV) United States $41.183B 23.89
STERIS (STE) Ireland $22.787B 26.63
Waters (WAT) United States $20.691B 30.41
SONOVA HOLDING (SONVY) Switzerland $18.917B 0.00
Hologic (HOLX) United States $17.459B 19.53
ShockWave Medical (SWAV) United States $12.540B 78.04
Fresenius Medical Care AG KGaA (FMS) Germany $12.235B 14.28
Sysmex ADR (SSMXY) Japan $10.844B 34.01
Teleflex (TFX) United States $10.037B 15.62
Globus Medical (GMED) United States $9.090B 26.65
Penumbra (PEN) United States $7.713B 87.65
Masimo (MASI) United States $6.721B 38.72
Glaukos (GKOS) United States $5.426B 0.00
TransMedics (TMDX) United States $4.511B 428.03
Integer Holdings (ITGR) United States $4.073B 24.61
PROCEPT BioRobotics (PRCT) United States $3.449B 0.00
Tandem Diabetes Care (TNDM) United States $3.319B 0.00
LivaNova (LIVN) United Kingdom $3.280B 19.48
Elekta AB (EKTAY) Sweden $3.078B 21.12
Inari Medical (NARI) United States $2.771B 0.00
Nihon Kohden (NHNKY) Japan $2.493B 21.08
RxSight (RXST) United States $2.285B 0.00
Integra LifeSciences Holdings (IART) United States $2.216B 9.66
Veracyte (VCYT) United States $1.653B 0.00
Alphatec Holdings (ATEC) United States $1.505B 0.00
Artivion (AORT) United States $0.991B 95.04
AVANOS MEDICAL, INC (AVNS) United States $0.935B 18.18
OPKO Health (OPK) United States $0.920B 0.00
Silk Road Medical (SILK) United States $0.878B 0.00
OrthoPediatrics (KIDS) United States $0.790B 0.00
Pulse Biosciences (PLSE) United States $0.659B 0.00
Paragon 28 (FNA) United States $0.653B 0.00
Mesa Laboratories (MLAB) United States $0.617B 20.94
SiBone (SIBN) United States $0.578B 0.00
IRadimed (IRMD) United States $0.551B 30.88
ORTHOFIX MEDICAL INC (OFIX) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.504B 0.00
Nevro (NVRO) United States $0.360B 0.00
Treace Medical Concepts (TMCI) United States $0.331B 0.00
Tactile Systems Technology (TCMD) United States $0.307B 10.50
AxoGen (AXGN) United States $0.271B 0.00
Sight Sciences (SGHT) United States $0.261B 0.00
AngioDynamics (ANGO) United States $0.253B 0.00
908 Devices (MASS) United States $0.233B 0.00
NeuroPace (NPCE) United States $0.228B 0.00
EDAP TMS S.A (EDAP) France $0.223B 0.00
Delcath Systems (DCTH) United States $0.218B 0.00
Inogen (INGN) United States $0.204B 0.00
Atossa Genetics (ATOS) United States $0.192B 0.00
Alpha Tau Medical (DRTS) Israel $0.189B 0.00
CVRx (CVRX) United States $0.184B 0.00
ClearPoint Neuro (CLPT) United States $0.166B 0.00
Semler Scientific (SMLR) United States $0.165B 8.37
Accuray (ARAY) United States $0.152B 0.00
Yubo Biotech (YBGJ) China $0.110B 0.00
KORU Medical Systems (KRMD) United States $0.102B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.096B 20.10
Neuronetics (STIM) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Monogram Orthopaedics (MGRM) United States $0.063B 0.00
Vicarious Surgical (RBOT) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
Envoy Medical (COCH) United States $0.059B 0.00
SEP Acquisition (SEPA) United States $0.052B 0.00
DarioHealth (DRIO) United States $0.052B 0.00
Autonomix Medical (AMIX) United States $0.048B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
LENSAR (LNSR) United States $0.047B 0.00
ReWalk Robotics (LFWD) Israel $0.043B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Pixie Dust Technologies (PXDT) Japan $0.035B 0.00
Aspira Women's Health (AWH) United States $0.031B 0.00
T2 Biosystems (TTOO) United States $0.031B 0.00
Spectral AI (MDAI) United States $0.029B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.025B 0.00
Accelerate Diagnostics (AXDX) United States $0.023B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
NexGel (NXGL) United States $0.015B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.011B 0.00
Avinger (AVGR) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00